Quick Takeaways
- ABG Management Ltd. filed SCHEDULE 13G for ProMIS Neurosciences Inc. Common Shares, no par value per share (PMN).
- Disclosed ownership: 12%.
- Date of event: 29 Jul 2025.
ABG Management Ltd. - 29 Jul 2025 SCHEDULE 13G Report for ProMIS Neurosciences Inc. Common Shares, no par value per share (PMN)
- Filing Manager
- ABG Management Ltd.
- Reporting Manager
- ABG Management Ltd.
- Symbol
- PMN
- Shares outstanding
- 51,345,237 shares
- Disclosed Ownership
- 6,058,738 shares
- Ownership
- 12%
- Form type
- SCHEDULE 13G
- Filing time
- 04 Aug 2025, 17:55:02 UTC
- Date of event
- 29 Jul 2025
- Next filing
- 29 Oct 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"ABG Management Ltd. disclosed 12% ownership in ProMIS Neurosciences Inc. Common Shares, no par value per share (PMN) on 29 Jul 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 04 Aug 2025, 17:55.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ABG Management Ltd. | 12% | 6,058,738 | 0 | 6,058,738 | By: /s/ Fan Yu | Fan Yu, Director | |
| Ally Bridge Group (NY) LLC | 12% | 6,058,738 | 0 | 6,058,738 | By: ABG Management Ltd., its managing member, By: /s/ Fan Yu | Fan Yu, Director | |
| Ally Bridge MedAlpha Master Fund L.P. | 12% | 6,058,738 | 0 | 6,058,738 | By: Ally Bridge Group (NY) LLC, its manager, By: ABG Management Ltd., its managing member, By: /s/ Fan Yu | Fan Yu, Director | |
| Fan Yu | 12% | 6,058,738 | 0 | 6,058,738 | /s/ Fan Yu | Fan Yu |